Ladone Mary Kay

Ladone Mary Kay is listed in filings as Director at Bioventus Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including 13 public disclosures. Recent filings connect the profile to Bioventus Inc. (BVS), Novanta Inc. - Common Shares (NOVT), Kestra Medical Technologies, Ltd. (KMTS), and Inogen, Inc. (INGN). The current snapshot covers public activity from Jun 13, 2024 to Jun 4, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.